GlaxoSmithKline

Queens of influence: Meet the women shaping Europe’s future
Conferences

Queens of influence: Meet the women shaping Europe’s future

By
May 23, 2025
Emma Walmsley, chief executive officer of GSK Plc, following a Bloomberg Television interview in London, UK, on Tuesday, July 16, 2024. The threat of superbugs is not sufficiently understood, Walmsley said.
Leadership

GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt

By
April 2, 2025
‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
Tech

‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse

By
March 25, 2025
Emma Walmsley, chief executive officer of GlaxoSmithKline speaks during the Clinton Global Initiative annual meeting in New York City on September 24, 2024.
Health

GSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.

By
February 28, 2025
GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales
Finance

GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales

By
February 5, 2025
British pharma giant GSK to acquire U.S. drug developer IDRx in $1.15 billion deal
Retail

British pharma giant GSK to acquire U.S. drug developer IDRx in $1.15 billion deal

By
January 14, 2025
A white sign featuring the Pfizer logo
Health

GSK, Pfizer RSV shots must warn about rare paralysis risk

By
January 8, 2025
As you dive into your New Year’s resolutions, taking precautions to protect yourself from a quartet of infectious diseases can lessen your odds of starting off 2025 sick.
Health

Public health experts are warning of a ‘quad-demic’ this winter. Here’s where flu, COVID, RSV, and norovirus are spreading

By
December 18, 2024
British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
Retail

British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance

By
October 30, 2024
British pharma giant GSK strikes $2.3 billion deal to put an end to 80,000 U.S. lawsuits
Retail

British pharma giant GSK strikes $2.3 billion deal to put an end to 80,000 U.S. lawsuits

By
October 10, 2024
As of spring 2024, at which time two RSV vaccines had been FDA-approved, less than 25% of eligible U.S. adults 60 and older had gotten one, according to the CDC.
Aging Well

RSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine

By
October 4, 2024
Photo of Anne Wojcicki
Success

Every single member of the board just resigned from DNA tester 23andMe

By
September 18, 2024
Zantac heartburn medicine are seen at a store in Mountain View, California
Retail

Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit, but thousands still to come

By Jef Feeley, Ashleigh Furlong and Bloomberg
May 24, 2024
Emma Walmsley attends the 10th Annual Breakthrough Prize Awards and Ceremony at the Academy Museum of Motion Pictures in Los Angeles, California, United States
Health

How GSK CEO Emma Walmsley kept her job and turned a belligerent activist investor into an ally

By Ashleigh Furlong, Sabah Meddings and Bloomberg
May 21, 2024
Aerial view of the City of London skyscrapers at night
Finance

London share sales have hit $11.3 billion for the year to date—despite an IPO drought, that’s still three times more than Paris

By Joe Easton and Bloomberg
May 20, 2024

Most Popular